Category Archives: Public Policy

Latest From Public Policy

BIO CEO: Patient Groups Join Call for Data Protection

Biomedical innovation is not only key to our industry’s future, but more importantly, continued medical breakthroughs are vital to patients living with debilitating diseases and their families. Without ongoing progress in our industry, patients of today and tomorrow have limited hope for future cures and therapies.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

For July 4: Let’s Thank the Inventors

My hope for America this July 4? I hope, in 100 years, the response time to human and environmental suffering will be immediate. Until that day arrives (thanks to scientific breakthroughs funded by individual citizens) — let’s thank our scientists, investors, and inventors who work and play around us.

Finally, let’s also thank the founding fathers for knowing America’s innovative potential without seeing it for themselves.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Twitter Twang: July 1st

Twitter Twang: July 1st

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

Twitter Twang: June 30th

Here’s this morning’s Twitter Twang!

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

Holman: Follow-on Biologics Bill Threatens Innovation By Weakening Patent Rights

Chris Holman, Professor at the University of Missouri-Kansas City School of Law and author of Holman’s Biotech IP Blog, recently posted a great summary of the patent provisions in the follow-on biologics bill currently under consideration in Congress.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: